Drug reference

nusinersen

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 966

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(neu-si-ner′sen) Spinraza

PDF page 966

Functional class

Func. class.: Miscellaneous CNS agent muscular dystrophy

PDF page 966

Chemical class

Chem. class.: Antisense oligonu- cleotide

PDF page 966

Do not confuse

Do not confuse: Nusinersen/Neurontin Nucynta, Sprinraza/Spriva

PDF page 966

Uses

USES: Spinal muscular atrophy

PDF page 966

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult/child: Intrathecal 12 mg q14days 3 doses, then 12 mg q30days after third dose; maintenance 12 mg q4mo thereafter

PDF page 966

Available forms

Available forms: Injection 12 mg/5 mL single-use vials

PDF page 966

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

nusinersen

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 966

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(neu-si-ner′sen) Spinraza

PDF page 966

Functional class

Func. class.: Miscellaneous CNS agent muscular dystrophy

PDF page 966

Chemical class

Chem. class.: Antisense oligonu- cleotide

PDF page 966

Do not confuse

Do not confuse: Nusinersen/Neurontin Nucynta, Sprinraza/Spriva

PDF page 966

Uses

USES: Spinal muscular atrophy

PDF page 966

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult/child: Intrathecal 12 mg q14days 3 doses, then 12 mg q30days after third dose; maintenance 12 mg q4mo thereafter

PDF page 966

Available forms

Available forms: Injection 12 mg/5 mL single-use vials

PDF page 966

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.